Trial Details
ENROLLING_BY_INVITATIONBasic Information
| Clinical ID | c1557 |
|---|---|
| Identifier | NCT04880876 |
| Trial Title | A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome |
| Interventions | DRUG: 25mg Eluxadoline|DRUG: 100mg Eluxadoline |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Corona |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2021-08-13 |
|---|---|
| Primary Completion Date | 2032-12 |
| Completion Date | 2032-12 |